The story of Viagra, and its creator copyright, presents a challenging case study for investors. Initially a blockbuster drug, producing billions in sales , its exclusivity period created a flood of generic competition , significantly eroding its dominance. While some pharmaceutical companies may seek to capitalize on related treatments , the exist